NCT05742503

Progesterone Containing Contraceptive Methods on Endogenous Progesterone Level

Effects of Different Progesterone Containing Contraceptive Methods on Safety and Endogenous Progesterone Level

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 80 (actual)
• Sponsor: Tanta University · Academic / Other
• Sex: Female
• Age: 20 Years – 35 Years
• Healthy volunteers: Accepted

Summary

The aim of this study is to assess the effect of different progesterone containing contraceptive methods on safety and endogenous progesterone level

Detailed description

Progestogen-only' contraceptives are presented as injections, implants, oral formulations, hormone-releasing intrauterine methods and emergency contraceptives. These substances could be used by females who are breastfeeding or have other contraindications to estrogen treatment, including those who are immediately postpartum, have thalassemia, sickle-cell disease, gallbladder disease, or currently experiencing thrombo-embolic disorders, valvular heart disease, ischemic heart disease. Intrauterine, injectable methods and contraceptive implants named as long-acting reversible contraceptives (LARC) are the more efficient reversible contraceptive approaches are highly effective, longer-acting contraceptive methods levels.

Conditions

• Progesterone
• Contraceptive Methods

Interventions

Type	Name	Description
OTHER	Depo-Provera	Injectable progesterone
OTHER	Implanon	Etonogestrel implant
OTHER	Norgestrel	Pill containing progesterone
OTHER	Mirena	Levonorgestrel-releasing intra-uterine drug (IUD)

Timeline

• Start date: 2021-03-30
• Primary completion: 2022-03-30
• Completion: 2022-03-30
• First posted: 2023-02-24
• Last updated: 2023-02-24

Locations

1 site across 1 country: Egypt